03 November 2025

These two robotic devices will facilitate earlier and more efficient recovery for patients with mobility difficulties in their legs. HUB has this equipment for the first time thanks to a global purchasing programme by the Department of Health, which has acquired 13 for centres with Clinical Expertise Units (UEC).

17 October 2025

The Catalan Institute of Oncology, Bellvitge University Hospital and IDIBELL, with the support of the University of Barcelona, have been accredited by the OECI as a Comprehensive Cancer Centre (CCC) – the highest European recognition for the integrated approach to cancer care

This is the only CCC in Spain and Catalonia that brings together four independent public institutions working in a coordinated and networked manner, with a team of more than 1,500 professionals leading activities ranging from research and prevention to comprehensive patient care

28 August 2025

Since performing the first two liver transplants in the entire country 41 years ago, HUB has established itself as a reference center for this procedure. In addition, the hospital’s Liver Transplant Unit has, in recent years, strengthened collaboration with regional hospitals and advanced research to improve surgical outcomes.

20 August 2025

With a comprehensive and multidisciplinary care model, the new functional unit has managed to reduce the waiting time for a first visit to just 15 days. The Memory Unit at Bellvitge University Hospital (HUB) is the reference team for cognitive assessment for residents of southern L’Hospitalet de Llobregat and El Prat de Llobregat, and provides care to more than 2,000 people.
 

08 July 2025

A recent study led by Dr. Marta Simó and Dr. Jordi Bruna, principal investigators of the Neurooncology group at Hospital de Bellvitge-IDIBELL-ICO, in collaboration with members of the Functional Lung Unit, such as Dr. Susana Padrones and Dr. Ernest Nadal, was recently published in the journal Neurology.

30 June 2025

A study with 600 patients confirms the value of the neuron-specific enolase (NSE) protein as a predictor of poor neurological prognosis.

It can help guide more accurate medical decisions during the crucial first hours of hospital admission.